Skip to main content
. 2024 Jul 25;25(15):8121. doi: 10.3390/ijms25158121

Figure 4.

Figure 4

Invasion ability of EOC-cell-line-derived exosomes. Their invasion ability was examined in ES2 (A) and SKOV3 (B) treated with ES2, ES2TR, ES2 tumor sphere, and ES2TR tumor sphere exosomes and not treated with said exosomes. The invasion ability of exosomes from ES2, ES2 TS, ES2TR, and ES2TR TS was more remarkably enhanced in ES2 than in SKOV3 (*** p < 0.001 for ES2 and ** p < 0.01 for SKOV3, respectively).